Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1711
    +0.0018 (+0.15%)
     
  • GBP/USD

    1.2620
    -0.0002 (-0.02%)
     
  • Bitcoin GBP

    55,687.82
    +464.00 (+0.84%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,365.65
    +197.58 (+0.49%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

Hunan Hansen Pharmaceutical Co. Ltd. : Overvalued relative to peers, but may deserve another look

Hunan Hansen Pharmaceutical Co. Ltd. : Overvalued relative to peers, but may deserve another look

Categories: Yahoo Finance Hunan Hansen Pharmaceutical Co. Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 53. Our analysis is based on comparing Hunan Hansen Pharmaceutical Co. Ltd. with the following peers – Mayinglong Pharmaceutical Group Co., Ltd. Class A, Jiangsu Hengrui Medicine Co., Ltd. Class A, Jilin Zixin ... Read more (Read more...)